Rebamipide May Combat Low-Grade Inflammation in Post-COVID-19 Syndrome Patients

Participants receiving Rebamipide experience significant improvement of CRP plasma levels in peripheral blood. MILWAUKEE, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Rebamipide may be useful for rehabilitation of patients with SARS-CoV-2 post-COVID syndrome according to new research being...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI SVY Source Type: news